{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:30:06Z","timestamp":1789727406261,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012401","name":"Beijing Science and Technology Planning Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.cca.2019.11.004","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T19:37:06Z","timestamp":1573587426000},"page":"222-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Diagnostic efficacy of serum anti-phospholipase A2 receptor antibodies for idiopathic membranous nephropathy in patients with diabetic kidney disease"],"prefix":"10.1016","volume":"502","author":[{"given":"Qian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-yi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-guang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-lun","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-wei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-jie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Yu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-feng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-yan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.cca.2019.11.004_b0005","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2013.168118","article-title":"Noncommunicable Disease Surveillance, Prevalence and control of diabetes in Chinese adults","volume":"310","author":"Xu","year":"2013","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.cca.2019.11.004_b0010","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1001\/jama.2017.7596","article-title":"Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013","volume":"317","author":"Wang","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2019.11.004_b0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"6","key":"10.1016\/j.cca.2019.11.004_b0020","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/jama.2016.10924","article-title":"Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988\u20132014","volume":"316","author":"Afkarian","year":"2016","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.cca.2019.11.004_b0025","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.2337\/dc13-0298","article-title":"Study Group for Renal, Hypertension, Long-term outcomes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy","volume":"36","author":"Shimizu","year":"2013","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.cca.2019.11.004_b0030","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMc1602469","article-title":"Trends in chronic kidney disease in China","volume":"375","author":"Zhang","year":"2016","journal-title":"N Engl. J. Med."},{"issue":"24","key":"10.1016\/j.cca.2019.11.004_b0035","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.4103\/0366-6999.247197","article-title":"Clinicopathological features of nondiabetic renal diseases from different age groups: an observational cross-sectional study","volume":"131","author":"Liu","year":"2018","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"2019","key":"10.1016\/j.cca.2019.11.004_b0040","first-page":"81","article-title":"Validation of the kidney disease outcomes quality initiative clinical practice guideline for the diagnosis of diabetic nephropathy and nondiabetic renal disease in Chinese patients","volume":"147","author":"Liu","year":"2007","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cca.2019.11.004_b0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000348638","article-title":"Changing spectrum of biopsy-proven primary glomerular diseases over the past 15 years: a single-center study in China","volume":"181","author":"Pan","year":"2013","journal-title":"Contrib. Nephrol."},{"issue":"12","key":"10.1016\/j.cca.2019.11.004_b0050","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1681\/ASN.2016010093","article-title":"Long-term exposure to air pollution and increased risk of membranous nephropathy in China","volume":"27","author":"Xu","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.cca.2019.11.004_b0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl. J. Med."},{"issue":"8","key":"10.1016\/j.cca.2019.11.004_b0060","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1093\/ndt\/gfr247","article-title":"An immunofluorescence test for phospholipase-A(2)-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis","volume":"26","author":"Hoxha","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"issue":"6","key":"10.1016\/j.cca.2019.11.004_b0065","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1681\/ASN.2010090967","article-title":"Anti-phospholipase A2 receptor antibody in membranous nephropathy","volume":"22","author":"Qin","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.cca.2019.11.004_b0070","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1681\/ASN.2014050502","article-title":"Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy","volume":"26","author":"Fresquet","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9981","key":"10.1016\/j.cca.2019.11.004_b0075","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/S0140-6736(15)60731-0","article-title":"Pathophysiological advances in membranous nephropathy: time for a shift in patient's care","volume":"385","author":"Ronco","year":"2015","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.cca.2019.11.004_b0080","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Int. Med."},{"issue":"7","key":"10.1016\/j.cca.2019.11.004_b0085","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabetic Med. J. Br. Diabetic Assoc."},{"issue":"6","key":"10.1016\/j.cca.2019.11.004_b0090","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2215\/CJN.11761116","article-title":"Primary membranous nephropathy","volume":"12","author":"Couser","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.cca.2019.11.004_b0095","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ki.2010.34","article-title":"Membranous nephropathy: recent travels and new roads ahead","volume":"77","author":"Beck","year":"2010","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.cca.2019.11.004_b0100","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/ki.2013.375","article-title":"Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification","volume":"85","author":"Haas","year":"2014","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.cca.2019.11.004_b0105","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1053\/j.ajkd.2015.07.006","article-title":"AJKD atlas of renal pathology: membranous nephropathy","volume":"66","author":"Fogo","year":"2015","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"10.1016\/j.cca.2019.11.004_b0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1309\/AJCP8QMOY5GLRSFP","article-title":"Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study","volume":"142","author":"Timmermans","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.cca.2019.11.004_b0115","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000440983","article-title":"Anti-phospholipase A2 receptor antibody as prognostic indicator in idiopathic membranous nephropathy","volume":"42","author":"Kim","year":"2015","journal-title":"Am. J. Nephrol."},{"issue":"9","key":"10.1016\/j.cca.2019.11.004_b0120","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/ndt\/gfv399","article-title":"PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in South Asians","volume":"31","author":"Ramachandran","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3","key":"10.1016\/j.cca.2019.11.004_b0125","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.pathol.2016.02.001","article-title":"Validation of a phospholipase A2 receptor antibody ELISA in an Australian cohort with membranous glomerulonephritis","volume":"48","author":"Ong","year":"2016","journal-title":"Pathology"},{"issue":"6","key":"10.1016\/j.cca.2019.11.004_b0130","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s11255-016-1263-6","article-title":"The accuracy of the anti-phospholipase A2 receptor antibody in the diagnosis of idiopathic membranous nephropathy: a comparison of different cutoff values as measured by the ELISA method","volume":"48","author":"Dou","year":"2016","journal-title":"Int. Urol. Nephrol."},{"issue":"1","key":"10.1016\/j.cca.2019.11.004_b0135","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.ajkd.2016.01.030","article-title":"Membranous nephropathy: a journey from bench to bedside","volume":"68","author":"Francis","year":"2016","journal-title":"Am. J. Kidney Dis."},{"issue":"5","key":"10.1016\/j.cca.2019.11.004_b0140","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1681\/ASN.2016020114","article-title":"MHC Class II risk alleles and amino acid residues in idiopathic membranous nephropathy","volume":"28","author":"Cui","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.cca.2019.11.004_b0145","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1681\/ASN.2016060644","article-title":"HLA-DRB1*15:01 and HLA-DRB3*02:02 in PLA2R-Related Membranous Nephropathy","volume":"28","author":"Le","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.cca.2019.11.004_b0150","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1681\/ASN.2012080771","article-title":"Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy","volume":"24","author":"Lv","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.cca.2019.11.004_b0155","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000487136","article-title":"The genetic and environmental factors of primary membranous nephropathy: an overview from China","volume":"4","author":"Zhang","year":"2018","journal-title":"Kidney Dis. (Basel)"},{"key":"10.1016\/j.cca.2019.11.004_b0160","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.diabres.2016.09.005","article-title":"Clinical predictors differentiating non-diabetic renal diseases from diabetic nephropathy in a large population of type 2 diabetes patients","volume":"121","author":"Dong","year":"2016","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"3","key":"10.1016\/j.cca.2019.11.004_b0165","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1523-1755.2004.00833.x","article-title":"G. Spanish registry of clinicopathologic correlations of renal pathology in Spain","volume":"66","author":"Rivera","year":"2004","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.cca.2019.11.004_b0170","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0272-6386(03)00401-3","article-title":"Nephrotic syndrome and ARF in a diabetic patient","volume":"41","author":"Stokes","year":"2003","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.cca.2019.11.004_b0175","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s40620-017-0427-5","article-title":"Treatment of primary membranous nephropathy: where are we now?","volume":"31","author":"Angioi","year":"2018","journal-title":"J. Nephrol."},{"issue":"9","key":"10.1016\/j.cca.2019.11.004_b0180","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrneph.2017.92","article-title":"Treatment of membranous nephropathy: time for a paradigm shift","volume":"13","author":"Ruggenenti","year":"2017","journal-title":"Nat. Rev. Nephrol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119321205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119321205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:53:30Z","timestamp":1757861610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898119321205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":36,"alternative-id":["S0009898119321205"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2019.11.004","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic efficacy of serum anti-phospholipase A2 receptor antibodies for idiopathic membranous nephropathy in patients with diabetic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2019.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}